Health Canada
- Status: approved
Rapid and long acting insulin (Rapid and long acting insulin) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Albert Einstein College of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.